Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019;70:151–171
Trapero-Marugan M, Little EC, Berenguer M. Stretching the boundaries for liver transplant in the 21st century. Lancet Gastroenterol Hepatol. 2018;3:803–811
van Vugt J, Alferink L, Buettner S, Gaspersz MP, Bot D, Darwish MS, et al. A model including sarcopenia surpasses the meld score in predicting waiting list mortality in cirrhotic liver transplant candidates: a competing risk analysis in a national cohort. J Hepatol. 2018;68:707–714
Lee DH, Keum N, Hu FB, Orav EJ, Rimm EB, Willett WC, et al. Predicted lean body mass, fat mass, and all cause and cause specific mortality in men: prospective us cohort study. BMJ. 2018;362: k2575
Article PubMed PubMed Central Google Scholar
Reichelt S, Pratschke J, Engelmann C, Neumann UP, Lurje G, Czigany Z. Body composition and the skeletal muscle compartment in liver transplantation: turning challenges into opportunities. Am J Transplant. 2022;22:1943–1957
Pravisani R, Soyama A, Ono S, Baccarani U, Isola M, Takatsuki M, et al. Is there any correlation between liver graft regeneration and recipient’s pretransplant skeletal muscle mass?-A study in extended left lobe graft living-donor liver transplantation. Hepatobiliary Surg Nutr. 2020;9:183–194
Article PubMed PubMed Central Google Scholar
Tantai X, Liu Y, Yeo YH, Praktiknjo M, Mauro E, Hamaguchi Y, et al. Effect of sarcopenia on survival in patients with cirrhosis: a meta-analysis. J Hepatol. 2022;76:588–599
Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yao S, et al. Proposal for new selection criteria considering pre-transplant muscularity and visceral adiposity in living donor liver transplantation. J Cachexia Sarcopenia Muscle. 2018;9:246–254
Article PubMed PubMed Central Google Scholar
Onishi H, Yoshikawa R, Harada R, Matsumoto T, Kurashina T, Adachi A, et al. Investigation of changes in skeletal muscle mass and muscle quality and factors affecting changes in deceased donor liver transplantation. Transplant Proc. 2023;55:1649–1655
Chen H, Hu Z, Xu Q, He C, Yang X, Shen W, et al. The adverse impact of perioperative body composition abnormalities on outcomes after split liver transplantation: a multicenter retrospective cohort study. Int J Surg. 2024;110:3543–3553
Article PubMed PubMed Central Google Scholar
Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. Amstar 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358: j4008
Article PubMed PubMed Central Google Scholar
Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16
Article PubMed PubMed Central Google Scholar
Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2018;27:1785–1805
Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. Bmc Med Res Methodol. 2014;14:135
Article PubMed PubMed Central Google Scholar
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–1558
Lu D, Hu Z, Chen H, Khan AA, Xu Q, Lin Z, et al. Myosteatosis and muscle loss impact liver transplant outcomes in male patients with hepatocellular carcinoma. J Cachexia Sarcopenia Muscle. 2024;15:2071–2083
Article PubMed PubMed Central Google Scholar
Ari D, Dagli M, Gokcan H, Turan GD, Okten RS, Aydin O, et al. Effect of pretransplant sarcopenia on mortality in liver transplant recipients. Exp Clin Transplant. 2023;21:123–131
Molwitz I, Recklies F, Stark M, Horvatits T, Salamon J, Huber S, et al. Muscle quality determined by computed tomography predicts short-term and long-term survival after liver transplantation. Sci Rep. 2023;13:7631
Article CAS PubMed PubMed Central Google Scholar
Shafaat O, Liu Y, Jackson KR, Motter JD, Boyarsky BJ, Latif MA, et al. Association between abdominal ct measurements of body composition before deceased donor liver transplant with posttransplant outcomes. Radiology. 2023;306: e212403
Czigany Z, Kramp W, Lurje I, Miller H, Bednarsch J, Lang SA, et al. The role of recipient myosteatosis in graft and patient survival after deceased donor liver transplantation. J Cachexia Sarcopenia Muscle. 2021;12:358–367
Article PubMed PubMed Central Google Scholar
Irwin N, Fabian J, Hari KR, Lorentz L, Mahomed A, Botha JF. Myosteatosis, the more significant predictor of outcome: an analysis of the impact of myosteatosis, sarcopenia, and sarcopenic obesity on liver transplant outcomes in johannesburg, south africa. Exp Clin Transplant. 2021;19:948–955
Meister FA, Bednarsch J, Amygdalos I, Boecker J, Strnad P, Bruners P, et al. Various myosteatosis selection criteria and their value in the assessment of short- and long-term outcomes following liver transplantation. Sci Rep. 2021;11:13368
Article CAS PubMed PubMed Central Google Scholar
Shenvi SD, Taber DJ, Hardie AD, Botstein JO, Mcgillicuddy JW. Assessment of magnetic resonance imaging derived fat fraction as a sensitive and reliable predictor of myosteatosis in liver transplant recipients. HPB (Oxford). 2020;22:102–108
Bhanji RA, Takahashi N, Moynagh MR, Narayanan P, Angirekula M, Mara KC, et al. The evolution and impact of sarcopenia pre- and post-liver transplantation. Aliment Pharmacol Ther. 2019;49:807–813
Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yagi S, et al. Impact of skeletal muscle mass index, intramuscular adipose tissue content, and visceral to subcutaneous adipose tissue area ratio on early mortality of living donor liver transplantation. Transplantation. 2017;101:565–574
Montano-Loza AJ, Meza-Junco J, Baracos VE, Prado CM, Ma M, Meeberg G, et al. Severe muscle depletion predicts postoperative length of stay but is not associated with survival after liver transplantation. Liver Transpl. 2014;20:640–648
Li Z, Zhao Y, Xie Y, Zhang L, Sun Y, Yang K, et al. Impact of ct-relevant skeletal muscle parameters on post-liver transplantation survival in patients with hepatocellular carcinoma. Hepatol Int. 2024;18:1516–1527
Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, et al. Sarcopenia: revised european consensus on definition and diagnosis. Age Ageing. 2019;48:16–31
Czigany Z, Kramp W, Bednarsch J, van der Kroft G, Boecker J, Strnad P, et al. Myosteatosis to predict inferior perioperative outcome in patients undergoing orthotopic liver transplantation. Am J Transplant. 2020;20:493–503
Martin L, Birdsell L, Macdonald N, Reiman T, Clandinin MT, Mccargar LJ, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. 2013;31:1539–1547
Eslamparast T, Montano-Loza AJ, Raman M, Tandon P. Sarcopenic obesity in cirrhosis-the confluence of 2 prognostic titans. Liver Int. 2018;38:1706–1717
Wang L, Valencak TG, Shan T. Fat infiltration in skeletal muscle: influential triggers and regulatory mechanism. iScience. 2024;27:109221.
Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol. 2006;6:772–783
Article CAS PubMed Google Scholar
Agopian VG, Harlander-Locke MP, Markovic
Comments (0)